1-3 of 3
Jennifer Black
Close
Sort by
Journal Articles

The Pan-Bcl-2 Family Inhibitor 97C1 Targets Blast Crisis Chronic Myeloid Leukemia Stem Cells but Spares Normal Cord Blood Progenitor Cells

Daniel Goff, BS, Alice Shih, BS, Angela Court Recart, BS, MS, Larisa Balaian, Ph.D., Ryan Chuang, Anil Sadarangani, Ph.D., Heather Leu, BS, Qingfei Jiang, Ph.D., Annelie Schairer, MS, Jennifer Black, M.D., Russell Wall, BS, Christopher Kane, MD, FACS, Christina Jamieson, Ph.D., Raymond J. Tesi, MD, Catriona Jamieson, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 516.
https://doi.org/10.1182/blood.V116.21.516.516
Published: 2010
Journal Articles

The Use of DT388-IL3 Fusion Protein in Patients with Refractory Acute Myeloid Leukemia(AML).

Debashish Misra, M.D., Arthur Frankel, M.D., Philip Hall, Pharm.D., Tie Fu Liu, M.D., Jennifer Black, R.N., Joseph O. Moore, M.D., Carlos de Castro, M.D., Jon P. Gockerman, M.D., Cristina Gasparetto, M.D., Mitchell Horwitz, M.D., Patricia H. Davis, R.N., Nelson J. Chao, M.D., David A. Rizzieri, M.D.
Journal: Blood
Blood (2004) 104 (11): 4513.
https://doi.org/10.1182/blood.V104.11.4513.4513
Published: 2004
Journal Articles

A Phase II Study of Denileukin Diftitox (ONTAK R ) in Patients with Fludarabine Refractory B-Cell Chronic Lymphocytic Leukemia.

Philip Kuriakose, MD, Francesco Turturro, MD, Jesus G. Berdeja, MD, Robert Kerr, MD, Asha Surendranathan, Jennifer Black, Arthur E. Frankel, MD
Journal: Blood
Blood (2004) 104 (11): 4824.
https://doi.org/10.1182/blood.V104.11.4824.4824
Published: 2004